CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
50.17
-1.83 (-3.52%)
At close: Feb 4, 2026, 4:00 PM EST
50.27
+0.10 (0.20%)
After-hours: Feb 4, 2026, 4:09 PM EST
CRISPR Therapeutics AG Analyst Ratings
Total Analysts
20
Consensus Rating
Buy
Price Target
$71.95
Upside
+43.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $86 → $80 | Buy | Maintains | $86 → $80 | +59.46% | Jan 30, 2026 |
| Needham | Needham | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +59.46% | Dec 23, 2025 |
| Citizens | Citizens | Buy Reiterates $86 | Buy | Reiterates | $86 | +71.42% | Dec 23, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $82 → $74 | Strong Buy | Maintains | $82 → $74 | +47.50% | Nov 26, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $87 → $77 | Strong Buy | Maintains | $87 → $77 | +53.48% | Nov 12, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $42 → $50 | Hold | Maintains | $42 → $50 | -0.34% | Nov 11, 2025 |
| Baird | Baird | Hold Maintains $52 → $44 | Hold | Maintains | $52 → $44 | -12.30% | Nov 11, 2025 |
| Needham | Needham | Strong Buy Maintains $81 → $80 | Strong Buy | Maintains | $81 → $80 | +59.46% | Nov 10, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $78 → $93 | Strong Buy | Maintains | $78 → $93 | +85.37% | Oct 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +61.45% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +59.46% | Sep 23, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $70 | Buy | Initiates | $70 | +39.53% | Sep 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $65 → $80 | Strong Buy | Maintains | $65 → $80 | +59.46% | Aug 7, 2025 |
| Barclays | Barclays | Hold Maintains $42 → $56 | Hold | Maintains | $42 → $56 | +11.62% | Aug 6, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $82 | Strong Buy | Maintains | $82 | +63.44% | Aug 5, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $38 → $42 | Hold | Maintains | $38 → $42 | -16.28% | Aug 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.